SINGAPORE,Feb. 25,2025--Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"),a leading one-stop travel service provider of accommodation reservatio
BEIJING,Feb. 25,2025-- A news report from chinadaily.com.cn: On February 20,China National Petroleum Corporation (CNPC) announced the successful completion of the Well Shendi Take-1,reaching an impres
Trip.com Group to launch joint Technology Game Changers: Future Trends in Travel & Tourism report at ITB Berlin Press Conference
Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem
New agreement spans packet core,signaling,charging & policy solutions STOCKHOLM,Feb. 25,2025-- India\'s Bharti Airtel and Ericsson (NASDAQ: ERIC) have strengthened their longstanding partnership t
SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the
